Polyradiculoneuropathy: Clinical Trials

5 trials for Polyradiculoneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1

Follow Polyradiculoneuropathy: new trials by email Literature Review of Polyradiculoneuropathy trials Research Report on Polyradiculoneuropathy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC
Efgartigimod PH20 SC - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 4Completedargenx232024-12-102026-04-06
Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome
Armeo® Power 2 Exoskeleton - Active Rehabilitation with Feedback and Exercise Gaming, Armeo® Power 2 Exoskeleton - Passive Mobilization without Feedback - Guillain Barré Syndrome
Phase 4Active not recruitingI.R.C.C.S. Fondazione Santa Lucia622024-10-012026-09-18
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Immunoglobulin - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 4RecruitingUniversity of Aarhus602020-06-042024-05-17
IVIg for Demyelination in Diabetes Mellitus
10% intravenous immunoglobulin (IVIg), 0.9% sodium chloride - Peripheral Neuropathy, Diabetes Mellitus
Phase 4UnknownUniversity of Toronto252015-02-012016-11-11
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
Intravenous Immunoglobulins, Human, Methylprednisolone 500 MG Injection - Guillain-Barre Syndrome
Phase 4UnknownFirst Affiliated Hospital of Wenzhou Medical University4502013-01-022023-09-18

Narrower conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (4)  ·  Guillain-Barre Syndrome (2)  ·  Diabetes Mellitus (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyradiculopathy (1)

Broader conditions

Autoimmune Diseases (5)  ·  Autoimmune Diseases of the Nervous System (5)  ·  Chronic Disease (5)  ·  Demyelinating Diseases (5)  ·  Disease Attributes (5)  ·  Immune System Diseases (5)  ·  Nervous System Diseases (5)  ·  Neuromuscular Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Polyneuropathies (5)  ·  Peripheral Nervous System Diseases (4)  ·  Post-Infectious Disorders (2)  ·  Endocrine System Diseases (1)

Interventions

Immunoglobulins, Intravenous (2)  ·  Immunoglobulins (1)  ·  Injections (1)  ·  Methylprednisolone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

First Affiliated Hospital of Wenzhou Medical University (1)  ·  I.R.C.C.S. Fondazione Santa Lucia (1)  ·  University of Aarhus (1)  ·  University of Toronto (1)  ·  argenx (1)

Countries

Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Alex Martino Cinnera, PhD (1)  ·  Ari Breiner, MD, FRCPC (1)  ·  Diego Piatti, BSc (1)  ·  Henning Andersen, MD,DMSc,PhD (1)  ·  Laura Casagrande Conti, MSc (1)  ·  Martina D Arienzo, BSc (1)

Results publications

PMID 42578463

NIH funding

2018 (1)